Disciplinary Action against
Totada Shanthaveerappa, M.D.


In December 2005, the Georgia Composite State Board of Medical Examiners suspended the medical license of Totata R. Shanthaveerappa, M.D. (aka T.R. Shantha, M.D.). The action was taken after Shantha was indicted on charges of health care fraud, money laundering, and distributing unapproved and misbranded drugs. The suspension order also expressed concern that Shantha had treated cancer patients inappropriately. In 2007, Shantha pled guilty to one count of health care fraud, agreed to pay a total of $650,000 in asset forfeiture plus restitution, and was ordered to serve five years' probation followed by three years of supervised release. His medical license was revoked in May 2008.


BEFORE THE COMPOSITE STATE BOARD OF MEDICAL EXAMINERS

STATE OF GEORGIA

IN THE MATTER OF:

TOTADA SHANTHAVEERAPPA, M.D.
License No. 14721.
Respondent.

*
*
*
*
*


Dec 23, 2005

DOCKET NO. 20060063

ORDER OF SUMMARY SUSPENSION

1.

WHEREFORE, the Respondent is licensed by the Composite State Board of Medical Examiners ("Board") to practice as a physician in the State of Georgia.

2.

WHEREFORE, on or about December 21,2005, the Board received reliable information, that the Respondent had been indicted by the United States Attorney for the Northern District of Georgia on charges including, but not limited to, money laundering, health care fraud, the  treatment of patients with Dinitrophenol ("DNP”) and Ukrain, neither of which drugs has been, approved by the federal government for use in the United States, and the misbranding of DNP.

3.

WHEREFORE, on or about December 22, 2005, the Board received a letter from Respondent in which Respondent admitted that he had treated patients with DNP approximately three years ago and admitted that he was currently treating patients with Ukrain and as attachments to said letter provided the Board with copies of prescriptions for Ukrain written by Respondent in November of 2005 for his patients.

4.

WHEREFORE, in or about December of 2005, the Board received reliable information that the Respondent had mislabeled drugs in violation of the Georgia Board of Pharmacy rules and regulations governing the labeling of dangerous drugs and controlled substances and that Respondent had failed to maintain the records required by said rules and regulations for the dispensing of Schedule II drugs.

5.

WHEREFORE, the Board received reliable information that Respondent had treated a cancer patient in 2001 with doses of methotrexate that were so high that they posed an unreasonable and significant risk to the patient who subsequently died from complications caused by the methotrexate.

6.

NOW THEREFORE, the Board finds that Respondent Totada Shanthaveerappa's continued ability to practice as a physician poses a threat to the public health, safety and welfare and imperatively requires emergency action, it is hereby ORDERED that the license of Respondent to practice as a physician in the State of Georgia be and is hereby SUSPENDED, pursuant to O.C.G.A. § 50-13-18(c)(1), O.C.G.A. §§ 43-1-19(b) and 43-34-37, pending proceedings for further Board action which shall be promptly instituted and determined.

If the Respondent wishes to avail himself of the opportunity for an expedited hearing under O.C.G.A. § 50-13-18(c)(1), Respondent shall execute and file with the Docket Clerk of the Office of State Administrative Hearings, the original and one copy of the attached "Request for Expedited Hearing." Respondent shall also mail a copy to the attorney for the Board, whose name and address is listed on the Notice of Hearing.

This Order is signed and attested hy the Executive Director on behalf of the Composite State Board of Medical Examiners.

This 23 day December 2005

COMPOSITE STATE BOARD OF MEDICAL EXAMINERS

V. VINAYAK KAMATH, M.D.
President

_____________________
LASHARN HUGHES
Executive Director

PLEASE DIRECT ALL
COMMUNICATIONS TO:

AMELIA W. BAKER
Assistant Attorney General
40 Capitol Square, S.W.
Atlanta, Georgia 30334
Telephone: (404) 657-5759

This page was posted on November 6, 2008.

Links to Recommended Companies